VaramirStart free · no cardSign in
MBX as of Oct 31 · 15:49 ET
MBXNasdaqPharmaceutical Preparations

MBX Biosciences, Inc. · Brief

Next report

5 days

Nov 5 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
0 of 6≥ implied
avg implied
±19.9%
avg realized
±6.9%
Mar 17 '25—▲+1.72%—
May 12 '25±12.4%▲+0.27%×0.02
Aug 7 '25±46.4%▼−4.63%×0.10
Nov 6 '25±14.7%▲+9.71%×0.66
Jan 12 '26±17.0%▲+15.19%×0.89
Q1 FY26±16.9%▼−3.42%×0.20
May 7 '26±11.9%▲+8.06%×0.67
Q2 FY26—▼−0.55%—
quarterimplied−50%0+50%realized×
Q2 FY26—▼−0.55%—
May '26±11.9%▲+8.06%×0.67
Q1 FY26±16.9%▼−3.42%×0.20
Jan '26±17.0%▲+15.19%×0.89
Nov '25±14.7%▲+9.71%×0.66
Aug '25±46.4%▼−4.63%×0.10
2 older reports
May '25±12.4%▲+0.27%×0.02
Mar '25—▲+1.72%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 5 report · est.

Bull2 of 3

3disclosed supplier and customer ties in SEC filings across business partnersSEC filings
175managers reporting a position in the latest quarterly filings show broad ownership13F · Jun 30 '26

Bear2

9 of 24largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
20managers whose positions together make up the reported concentrated ownership of value13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

MBX report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 22impliedImplied move: ±18.3% into Nov 5 earnings (Oct 22 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.